During the past decade, Midwestern Regional Medical Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 13 clinical trials were completed, i.e. on average, 39.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midwestern Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "NRG Oncology" with 5 trials sponsored, "Puma Biotechnology, Inc." with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midwestern Regional Medical Center" #1 collaborator was "NRG Oncology" with 9 trials as a collaborator, "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Midwestern Regional Medical Center" are "Breast Cancer" (7 trials), "Recurrent Ovarian Carcinoma" (4 trials), "Lymphoma" (3 trials), "Ovarian Seromucinous Carcinoma" (3 trials) and "Primary Peritoneal High Grade Serous Adenocarcinoma" (3 trials). Many other conditions were trialed in "Midwestern Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Midwestern Regional Medical Center" are "Drug" (39 trials), "Biological" (14 trials), "Procedure" (14 trials), "Other" (11 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (8 trials), "Paclitaxel" (7 trials), "Magnetic Resonance Imaging" (6 trials), "Atezolizumab" (5 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Midwestern Regional Medical Center" are 31 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Midwestern Regional Medical Center". undefined are not yet recruiting, 9 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Midwestern Regional Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Midwestern Regional Medical Center, 6 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Midwestern Regional Medical Center has several departments that took part in Clinical trials: "Cancer Treatment Centers of America - Eastern Regional Medical Center" - 13 trials, "Cancer Treatment Centers of America at Southwestern Regional Medical Center" - 6 trials